Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President and CEO

Chief Operating Officer

Chief Medical Officer

Chief Scientific Officer

Chief Financial Officer

Chief Legal Officer

Senior VP & General Counsel

Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company's lead clinical candidate is VY-TAU01, an anti-tau antibody program for the treatment of Alzheimer's disease. It also develops VY-FXN01 to treat Friedreich's ataxia; superoxide dismutase 1 gene silencing program for the treatment of amyotrophic lateral sclerosis; and GBA1 gene replacement program to treat Parkinson's disease. In addition, the company develops research program for the treatment of Huntington's disease. It has collaboration and license agreements with Neurocrine Biosciences, Inc.; Pfizer Inc.; and Novartis Pharma, A.G. for the research, development, and commercialization of adeno-associated virus gene therapy products. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-02	Premium	sold	Premium	Premium	Premium	President and CEO
2024-04-02	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-04-01	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-02-21	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-02-21	Premium	sold	Premium	Premium	Premium	President and CEO
2024-02-21	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-02-21	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-02-20	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-02-09	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2024-02-09	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2024-02-09	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2024-02-09	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-02-09	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-01-17	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-01-17	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2023-10-03	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-10-01	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2023-09-15	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2023-09-15	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2023-07-06	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2023-06-30	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2023-06-30	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2023-04-03	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2023-04-03	Premium	sold	Premium	Premium	Premium	President and CEO
2023-03-20	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer

VYGR - Voyager Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for VYGR